# Ascend Gene & Cell Therapies Ltd. — Form D

Ascend Gene & Cell Therapies Ltd. of ALTRINCHAM, X0, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-01. The offering totals $66.6M, of which $66.6M was reported sold. Industry: Other.

## Offering

- Filed: 2023-03-01
- Form: D
- Accession: 0001967249-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $66.6M
- Amount sold: $66.6M
- Investors: 10
- Date of first sale: 2023-02-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-474622

## Issuer

- Name: Ascend Gene & Cell Therapies Ltd.
- CIK: 0001967249
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2021
- Address: 1 ASHLEY ROAD, ALTRINCHAM, X0, WA14 2DT
- Phone: 020-814-83794

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Michael Beecham | Director | Alachua, FL |
| Fred Cohen | Director | AUSTIN, TX |
| Timothy Funnell | Director | Alachua, FL |
| Andrew May | Director | Altrincham, X0 |
| Balaji Muralidhar | Director | Alachua, FL |
| Eric Shiozaki | Director | San Francisco, CA |
| Andrew Sinclair | Director | Watertown, MA |
| Timothy Funnell | Executive Officer | Alachua, FL |

## More

- [CIK 1967249 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1967249&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001967249-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.